메뉴 건너뛰기




Volumn 22, Issue 3, 2006, Pages 126-131

Review: Clinical transfusion management in sickle cell disease

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CREATININE; DEFERASIROX; DEFEROXAMINE; DEFEROXAMINE MESYLATE; HYDROXYUREA;

EID: 33750445632     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (21)
  • 1
    • 26444504833 scopus 로고    scopus 로고
    • Transfusion management in sickle cell disease
    • Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin N Am 2005;19:803-26.
    • (2005) Hematol Oncol Clin N Am , vol.19 , pp. 803-826
    • Wanko, S.O.1    Telen, M.J.2
  • 4
    • 17344391561 scopus 로고    scopus 로고
    • Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease
    • Talano JA, Hillery CA, Gottsschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:661-5.
    • (2003) Pediatrics , vol.111 , pp. 661-665
    • Talano, J.A.1    Hillery, C.A.2    Gottsschall, J.L.3
  • 5
    • 0036598527 scopus 로고    scopus 로고
    • Predicting the effect of transfusing only phenotype matched RBC's to patients with sickle cell disease: Theoretical and practical implications
    • Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype matched RBC's to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-91.
    • (2002) Transfusion , vol.42 , pp. 684-691
    • Castro, O.1    Sandler, S.G.2    Houston-Yu, P.3    Rana, S.4
  • 6
    • 0034858110 scopus 로고    scopus 로고
    • Prospective red blood cell phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial
    • Vichinsky EP, Luban NL, Wright E, et al. Prospective red blood cell phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
    • (2001) Transfusion , vol.41 , pp. 1086-1092
    • Vichinsky, E.P.1    Luban, N.L.2    Wright, E.3
  • 7
    • 33750479247 scopus 로고    scopus 로고
    • Medical Director, Carter BloodCare at Childrens. Personal communication
    • Nizzi F. Medical Director, Carter BloodCare at Childrens. Personal communication. 2004.
    • (2004)
    • Nizzi, F.1
  • 8
    • 0027958085 scopus 로고
    • Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
    • Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-42.
    • (1994) Blood , vol.83 , pp. 1136-1142
    • Kim, H.C.1    Dugan, N.P.2    Silber, J.H.3
  • 9
    • 33750455345 scopus 로고    scopus 로고
    • Bruce C. McLeod, editor. Bethesda MD, AABB Press: 146-50
    • Bruce C. McLeod, editor. Therapeutic apheresis: a physicians handbook. 1st ed. Bethesda MD, AABB Press: 2005;120-7, 146-50.
    • (2005) Therapeutic Apheresis: A Physicians Handbook. 1st Ed. , pp. 120-127
  • 10
    • 0037414164 scopus 로고    scopus 로고
    • Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment
    • Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-51.
    • (2003) JAMA , vol.289 , pp. 1645-1651
    • Steinberg, M.H.1    Barton, F.2    Castro, O.3
  • 11
    • 0031965089 scopus 로고    scopus 로고
    • Cerebrovascular accidents in sickle cell disease: Rates and risk factors
    • Ohene-Frempong K, Weiner SJ, Sleeper, LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
    • (1998) Blood , vol.91 , pp. 288-294
    • Ohene-Frempong, K.1    Weiner, S.J.2    Sleeper, L.A.3
  • 12
    • 4444309490 scopus 로고    scopus 로고
    • Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy
    • Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-52.
    • (2004) J Pediatr , vol.145 , pp. 346-352
    • Ware, R.E.1    Zimmerman, S.A.2    Sylvestre, P.B.3
  • 13
    • 0026034335 scopus 로고
    • High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
    • Wang WC, Kovnar EH, Tonkin IL, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;118:377-82.
    • (1991) J Pediatr , vol.118 , pp. 377-382
    • Wang, W.C.1    Kovnar, E.H.2    Tonkin, I.L.3
  • 14
    • 0026552537 scopus 로고
    • A modified transfusion program for prevention of stroke in sickle cell disease
    • Cohen AR, Martin MB, Silber JH et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-61.
    • (1992) Blood , vol.79 , pp. 1657-1661
    • Cohen, A.R.1    Martin, M.B.2    Silber, J.H.3
  • 15
    • 0032474692 scopus 로고    scopus 로고
    • Prevention of a first stroke by transfusions in children with sickle-cell anemia and abnormal results on transcranial Doppler ultrasonography
    • Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle-cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
    • (1998) N Engl J Med , vol.339 , pp. 5-11
    • Adams, R.J.1    McKie, V.C.2    Hsu, L.3
  • 16
    • 0035659821 scopus 로고    scopus 로고
    • Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia
    • Miller St, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-9.
    • (2001) J Pediatr , vol.139 , pp. 785-789
    • Miller, St.1    Wright, E.2    Abboud, M.3
  • 17
    • 0033976044 scopus 로고    scopus 로고
    • Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism
    • Mantadakis E, Ewalt DH, Cavender JD, et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000;95:78-82.
    • (2000) Blood , vol.95 , pp. 78-82
    • Mantadakis, E.1    Ewalt, D.H.2    Cavender, J.D.3
  • 18
    • 0027737943 scopus 로고
    • Association of sickle cell disease, priapism, exchange transfusion and neurological events: Aspen syndrome
    • Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: Aspen syndrome. J Urol 1993;150:1480-2.
    • (1993) J Urol , vol.150 , pp. 1480-1482
    • Siegel, J.F.1    Rich, M.A.2    Brock, W.A.3
  • 19
    • 0029027701 scopus 로고
    • A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
    • Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-13.
    • (1995) N Engl J Med , vol.333 , pp. 206-213
    • Vichinsky, E.P.1    Haberkern, C.M.2    Neumayr, L.3
  • 20
    • 20344384761 scopus 로고    scopus 로고
    • Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion
    • Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR. Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion. Pediatr Blood Cancer 2005;45:43-7.
    • (2005) Pediatr Blood Cancer , vol.45 , pp. 43-47
    • Fu, T.1    Corrigan, N.J.2    Quinn, C.T.3    Rogers, Z.R.4    Buchanan, G.R.5
  • 21
    • 33745062600 scopus 로고    scopus 로고
    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. November
    • Package insert: Exjade (deferasirox). Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. November 2005.
    • (2005) Package Insert: Exjade (Deferasirox)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.